Form 4 holding
PRESIDENT AND CEO, Director
Cara Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 13,109
- Estimated value
- $62,268
- Report date
- 28 Feb 2025
- Price
- $4.75
- Ownership
- Direct
Christopher Posner - PRESIDENT AND CEO, Director at Tvardi Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- PRESIDENT AND CEO, Director
- Issuer Symbol
- TVRD on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Christopher Posner since 18 May 2025
Holdings reported by Christopher Posner for Tvardi Therapeutics, Inc.
Transactions reported by Christopher Posner for Tvardi Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.